MedTrace Logo

Free Fatty Acid Induced Insulin Resistance

NCT01229059 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2023-08-15

No results posted yet for this study

Summary

This study aims to explore time-dependent effects of lipid infusion an intramyocellular lipid metabolites and the induction of impaired insulin signaling.

Conditions

Interventions

DIETARY_SUPPLEMENT

Lipovenös lipid infusion

Lipid enriched infusions will be applied for 2-6 hours.

Sponsors & Collaborators

  • Heinrich-Heine University, Duesseldorf

    collaborator OTHER

  • German Diabetes Center

    lead OTHER

Principal Investigators

  • Michael Roden, Prof., MD · German Diabetes Center

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2019-11-30
Completion
2019-11-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01229059 on ClinicalTrials.gov